Think Global, Act Local: Supporting Orphan Drug Development in NJ

Dana Cohen

You could say that I’m a Jersey Girl. Having lived all my life in the Garden State, it’s important to me to help give back to the New Jersey community that is home to our Princeton headquarters. So, I’m really proud that Certara has supported the approval of several orphan drugs for rare diseases, one of which was developed by a NJ-based company. In recognition of this work, we were recently designated as a finalist in the “Innovation Heroes” category of the NJBIZ 2015 Healthcare Heroes awards program. In this blog post, I’ll discuss how we’re using biosimulation technology to bring safer, more effective medications to the people of New Jersey and beyond.

Read More
Topics: Model-based Drug Development
Learn More
LinkedIn